| Sequence 1: | NP_727914.1 | Gene: | Lrp4 / 32552 | FlyBaseID: | FBgn0030706 | Length: | 2009 | Species: | Drosophila melanogaster |
|---|---|---|---|---|---|---|---|---|---|
| Sequence 2: | NP_000518.1 | Gene: | LDLR / 3949 | HGNCID: | 6547 | Length: | 860 | Species: | Homo sapiens |
| Alignment Length: | 955 | Identity: | 283/955 - (29%) |
|---|---|---|---|
| Similarity: | 424/955 - (44%) | Gaps: | 207/955 - (21%) |
- Green bases have known domain annotations that are detailed below.
|
Fly 198 SNCQN-SNESDENCNPEEDAVPNLQRDCEKTGIHVMCPRTFRCISKYWLCDGDDDCGDYSDETHC 261
Fly 262 GARTNCTDDQFECLNGFCIPRTWVCDGENDCKDFSDETHCNRTTCTDEHFTCNDGYCISLAFRCD 326
Fly 327 GEHDCNDNSDE--LKCAAVI------NSCPEGEFKCRGGLGGAGGPSGQCILNRFRCDGDNDCGD 383
Fly 384 WSDEENCPQKPSLCTSNEYKCADGTCIPKRWKCDKEQDCDGGEDENDCGSLGSEHPLTCGSDEFT 448
Fly 449 CNNGRCILKTWLCDGYPDCAAGEDEVECHLQCDLGQFLCPTKQNLTNLKICVHQKHICDGHNECP 513
Fly 514 AGEDEADCPKERKCSEPSPCEQLCIETTAGSNECACRLGYVMDKNKVNCTDIDECQYLTSPVCSQ 578
Fly 579 KCHNTMGSFKCSCETGYILRPDLRSCKALGGAMTLLVANRWDIRRVTLSNNRYSAIVKGLHNAIA 643
Fly 644 LDFHHRKGLMFWSDVSTDVI---KMVYMNGTRVRD-VIKWGLESPGGIAVDWIHDLLFWTDSGTR 704
Fly 705 RVEVSNFQGNLRTVIASYDLDKPRAIVVHPGEALAFWSDWGPNPKIERAYMDGTQRKVIISKGVT 769
Fly 770 WPNGLAIDFPNSKIYWADAKQHAIECSNLDGSDRNKIL--STHLPHPFALTLFEDTMYWTDWNTK 832
Fly 833 TVSAADKITGKEFRAVHENFHFPMDIHAYHPARQPEYADRCQKDRRGLRGGCSHLCLP----NKT 893
Fly 894 SRR--CGCPIGLSLKEDGKTCKSTADKLVLVARRKDIRLRHLRDNQADPNDVDMIVPLDNLKHAV 956
Fly 957 ALDWCSDTDFIYWTDVERSTINKAHLNGSYQQRVVHSNLVSPVGLALDWITDKLYWTDPSTNRIE 1021
Fly 1022 VATTN--------GKMRTLLIWEKLYKPRDI----VVNPI--------EGFMFWSDWG------- 1059
Fly 1060 --DDPMIERA---------NMDGHERVTITSKKLIYPNGLAIDYE 1093 |
| Gene | Sequence | Domain | Region | External ID | Identity |
|---|---|---|---|---|---|
| Lrp4 | NP_727914.1 | LDLa | 267..301 | CDD:238060 | 17/33 (52%) |
| LDLa | 306..340 | CDD:238060 | 14/35 (40%) | ||
| LDLa | 347..390 | CDD:238060 | 19/42 (45%) | ||
| LDLa | 397..431 | CDD:238060 | 14/33 (42%) | ||
| LDLa | 442..476 | CDD:238060 | 11/33 (33%) | ||
| LDLa | 480..521 | CDD:238060 | 7/40 (18%) | ||
| FXa_inhibition | 576..604 | CDD:464251 | 13/27 (48%) | ||
| LY | 634..671 | CDD:214531 | 10/39 (26%) | ||
| LY | 680..714 | CDD:214531 | 14/33 (42%) | ||
| LY | 718..760 | CDD:214531 | 15/41 (37%) | ||
| Ldl_recept_b | 740..777 | CDD:459654 | 11/36 (31%) | ||
| LY | 761..803 | CDD:214531 | 12/41 (29%) | ||
| LY | 806..838 | CDD:214531 | 13/33 (39%) | ||
| FXa_inhibition | 882..912 | CDD:464251 | 15/35 (43%) | ||
| LY | 946..985 | CDD:214531 | 2/38 (5%) | ||
| NHL | <967..1142 | CDD:302697 | 28/165 (17%) | ||
| LY | 988..1030 | CDD:214531 | 8/49 (16%) | ||
| NHL repeat | 998..1037 | CDD:271333 | 8/46 (17%) | ||
| NHL repeat | 1038..1080 | CDD:271333 | 13/71 (18%) | ||
| NHL repeat | 1084..1119 | CDD:271333 | 3/10 (30%) | ||
| FXa_inhibition | 1185..1220 | CDD:464251 | |||
| NHL | 1260..>1445 | CDD:302697 | |||
| NHL repeat | 1260..1296 | CDD:271320 | |||
| LY | 1292..1334 | CDD:214531 | |||
| NHL repeat | 1302..1337 | CDD:271320 | |||
| NHL repeat | 1345..1383 | CDD:271320 | |||
| FXa_inhibition | <1499..1525 | CDD:464251 | |||
| LY | 1600..1640 | CDD:214531 | |||
| LY | 1643..1686 | CDD:214531 | |||
| LY | 1688..1729 | CDD:214531 | |||
| FXa_inhibition | 1801..>1825 | CDD:464251 | |||
| LDLR | NP_000518.1 | Ldl_recept_a | 25..58 | CDD:395011 | 3/7 (43%) |
| Ldl_recept_a | 66..104 | CDD:395011 | 16/38 (42%) | ||
| Ldl_recept_a | 107..143 | CDD:395011 | 18/36 (50%) | ||
| Binding to Getah virus E1-E2 spike glycoproteins. /evidence=ECO:0000269|PubMed:38245515 | 146..233 | 37/97 (38%) | |||
| Ldl_recept_a | 147..179 | CDD:395011 | 13/31 (42%) | ||
| Ldl_recept_a | 195..231 | CDD:395011 | 19/44 (43%) | ||
| Ldl_recept_a | 235..270 | CDD:395011 | 14/34 (41%) | ||
| Ldl_recept_a | 278..308 | CDD:395011 | 9/29 (31%) | ||
| FXa_inhibition | 318..>346 | CDD:464251 | 8/42 (19%) | ||
| EGF_CA | 354..388 | CDD:214542 | 18/35 (51%) | ||
| LDL-receptor class B 1 | 397..438 | 12/40 (30%) | |||
| LY | 419..457 | CDD:214531 | 11/37 (30%) | ||
| LDL-receptor class B 2 | 439..485 | 15/45 (33%) | |||
| Ldl_recept_b | 439..483 | CDD:459654 | 13/43 (30%) | ||
| LDL-receptor class B 3 | 486..528 | 16/41 (39%) | |||
| Ldl_recept_b | 487..526 | CDD:459654 | 15/38 (39%) | ||
| LDL-receptor class B 4 | 529..572 | 12/42 (29%) | |||
| Ldl_recept_b | 529..569 | CDD:459654 | 11/39 (28%) | ||
| LY | 553..595 | CDD:214531 | 12/41 (29%) | ||
| LDL-receptor class B 5 | 573..615 | 15/41 (37%) | |||
| LDL-receptor class B 6 | 616..658 | 12/41 (29%) | |||
| Ldl_recept_b | 616..656 | CDD:459654 | 11/39 (28%) | ||
| FXa_inhibition | 671..711 | CDD:464251 | 15/40 (38%) | ||
| Clustered O-linked oligosaccharides | 721..768 | 11/103 (11%) | |||
| Disordered. /evidence=ECO:0000256|SAM:MobiDB-lite | 734..755 | 5/37 (14%) | |||
| Required for MYLIP-triggered down-regulation of LDLR. /evidence=ECO:0000269|PubMed:19520913 | 811..860 | 9/56 (16%) | |||
| NPXY motif. /evidence=ECO:0000269|PubMed:22509010 | 823..828 | 2/4 (50%) | |||
| Blue background indicates that the domain is not in the aligned region. | |||||